Aims and objectives
This website aims to help promote excellence in Mental Health research across the European CF Community.
On this site, you will find:
• easy access to resources
• a "toolkit" to facilitate implementation of annual MH screening in many European languages
• the latest news on the topic
• opportunities for training (e.g. at ECFS annual conference)
“Special CF Lunchtime Series” 2021-2022
The ECFS Psychosocial Special Interest Group and the ECFS Mental Health Working Group are happy to announce the dates of the next webinars as part of the “Special CF Lunchtime Series”
Webinars will be held on Wednesdays at 12:00-13:00 CET / 11:00-12:00 UK time
More information and how to register for each webinar will follow in due course.
Please save these dates in your calendars
- 27th Oct 2021
- 15th Dec 2021
- 23rd Feb 2022
- 27th April 2022
Target audience: All members of the multi-disciplinary team including doctors, nurses, dietitians, physiotherapists, psychologists, social workers etc.
Past webinars (available on the ECFS education platform):
27 October 2021 - A basic introduction for allied health professionals into CFTR modulator treatments
BackgroundA study in nine countries (the TIDES study) showed that depression and especially anxiety were elevated in patients with CF and in parents of children with CF. Elevations were two to three times those reported in community samples. People with untreated depression, anxiety or both:
• May be less likely to manage their treatment plans effectively.
• Tend to have worse lung function.
• May have a lower body mass index (BMI).
• Often experience more hospitalizations.
• May experience a lower quality of life.
From a survey of 1454 CF health professionals it is known that Mental health care delivery in CF is inadequate and highly variable across care centres and countries. Insufficient resources and a lack of standardisation, training and competency generated barriers to mental health provision.
The Cystic Fibrosis Foundation, in collaboration with the European Cystic Fibrosis Society, developed guidelines for screening and treating depression and anxiety. These guidelines provide recommendations for prevention, screening, clinical assessment, and psychological and/or pharmacological interventions